The Valley Desk

ArticleCancersPublished

Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
Cancers
Published
Subject terms
Reverse-phase Protein Array; Bortezomib; Pediatric Acute Myeloid Leukemia
PubMed ID
38672531
PubMed Central ID
PMC11048007
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal